comparemela.com

Latest Breaking News On - Tentative approval - Page 4 : comparemela.com

Gland Pharma receives Tentative Approval for Cangrelor for Injection

Gland Pharma receives Tentative Approval for Cangrelor for Injection
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

United-states
Drug-administration
Gland-pharma
Tentative-approval
Time-zone
Pharma-limited
United-states-food
Gland-pharma-limited

Gland Pharma receives Tentative Approval for Sugammadex Injection

Gland Pharma receives Tentative Approval for Sugammadex Injection
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

United-states
Drug-administration
Gland-pharma
Merck-sharp-dohme-corp
Tentative-approval
Time-zone
Pharma-limited
United-states-food
Sugammadex-injection
Single-dose-vial
Merck-sharp

Zydus Cadila's Sitagliptin base tablets receives Tentative Approval from FDA

Zydus Cadila's Sitagliptin base tablets receives Tentative Approval from FDA
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

United-states
Zydus-cadila
Zydu-sitagliptin
Zydus-cadila-sitagliptin
Drug-administration
Cadila-healthcare-ltd
Tentative-approval
Time-zone
United-states-food
Sitagliptin-phosphate
New-drug-application
Federal-food

Avenue Supermarts, Maruti Suzuki, Adani Ports in limelight

Avenue Supermarts total revenue for the quarter ended 30 June 2021 stood at Rs.5,183 crore, as compared to Rs. 3,883 crore in the same period last year. Earnings before Interest, Tax, Depreciation and Amortization (EBITDA) in Q1 FY22 stood at Rs. 224 crore, as compared to Rs. 112 crore in the corresponding quarter of last year. EBITDA margin stood at 4.3% in Q1 FY22 as compared to 2.9% in Q1 FY 21. Net Profit is at Rs. 95 crore for Q1 FY22, as compared to Rs. 40 crore in the corresponding quarter of last year. PAT margin stood at 1.8% in Q1 FY22 as compared to 1.0% in Q1 FY 21. Maruti Suzuki India said the company has launched Maruti Suzuki Smart Finance, a digital end-to-end online car financing platform. Maruti Suzuki Smart Finance is now made available for ARENA as well as NEXA customers. It is also available pan India. It covers a wide range of profiles to meet the demands of a diverse range of customers.

United-states
India
Merck-sharpe
Drug-administration
Dohme-corp-merck
Compucom-software
Tribal-area-development
Operations-maintenance-services
Avenue-supermarts
Suzuki-india
Maruti-suzuki-smart-finance
Suzuki-smart-finance

Sensex, Nifty advance on positive global stocks; breadth strong

Key benchmark indices are trading firm in early trade on buying demand in index pivotals. At 9:25 IST, the barometer index, the S&P BSE Sensex, was up 288.76 points or 0.55% at 52,674.95. The Nifty 50 index was up 83.90 points or 0.53% at 15,773.70. Upbeat Asian stocks boosted sentiment. The S&P BSE Mid-Cap index was up 0.63%. The S&P BSE Small-Cap index was up 0.93%. The market breadth, indicating the overall health of the market, is strong. On the BSE, 2090 shares rose and 574 shares fell. A total of 112 shares were unchanged. In economic data, the Industrial Production and Manufacturing Production data for May will be released today, 12 July 2021. Inflation rate for June is also due today, 12 July 2021.

Malaysia
Seoul
Soult-ukpyolsi
South-korea
Japan
Tokyo
United-states
India
China
Italy
Indonesia
Merck-sharpe

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.